Cost-Minimization Analysis of Baofukang Compared with Langyi in the Treatment of Pregnancy with Vulvovaginal Candidiasis
- Author:
Xiao-Min DUAN
1
Author Information
- Publication Type:Journal Article
- Keywords: Cost-minimization analysis; Pharmacoeconomic evaluation; Pregnancy with VVC
- From: Chinese Pharmaceutical Journal 2017;52(13):1183-1187
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To conduct an economic evaluation of Baofukang versus Langyi in the treatment of pregnancy with vulvovaginal candidiasis by means of cost-minimization analysis. Furthermore, provide reference for reasonable clinical prescription and decision-making. METHODS: Meta-analysis was conducted to support the safety data and effectiveness data of pharmacoeconomic evaluation based on literature review; guidelines and clinical experts' suggestion were used to find out treatment routes to calculate total direct medical costs. Cost-minimization analysis was conducted from the societal perspective. RESULTS: The total direct medical costs of group Baofukang was lower than group Langyi's. Sensitivity analysis indicated the results were robust. CONCLUSION: In contrast with Langyi, Baofukang is a more economic therapy in the treatment of pregnancy with vulvovaginal candidiasis.
